African Journal of Infectious Diseases Research

ISSN 2756-3340

Table of Contents 2026

African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 972–979

DOI: 10.46882/AJIDR/149039

Article Type: Research Article

Title: Seroprevalence and molecular epidemiology of hepatitis D virus co-infection among chronic hepatitis B surface antigen carriers

Names of Authors: Nadia Benali-Mansour¹*, Lukas Novak², Samuel Boateng-Mensah³

Abstract: Hepatitis D virus is a defective satellite RNA virus requiring hepatitis B surface antigen for assembly, accelerating progression to liver cirrhosis and hepatocellular carcinoma. We determined anti-hepatitis D antibody prevalence, viral RNA viremia, and genotype distribution among chronic hepatitis B outpatients. Serum samples from 410 surface antigen-positive adults were screened via competitive enzyme-linked immunosorbent assay and reverse transcription quantitative polymerase chain reaction. Anti-hepatitis D seropositivity reached 12.4 percent, with genotype 1 strains predominating among viremic patients exhibiting advanced hepatic fibrosis. Universal hepatitis B immunization and reflex delta screening curb severe liver disease.

Keywords: Hepatitis D virus, Hepatitis B co-infection, Hepatic fibrosis, Viral genotypes, Chronic viral hepatitis

Citation: Benali-Mansour N, Novak L, Boateng-Mensah S (2026). Seroprevalence and molecular epidemiology of hepatitis D virus co-infection among chronic hepatitis B surface antigen carriers. African Journal of Infectious Diseases Research, 13(11): 972–979. DOI: 10.46882/AJIDR/149039

Manuscript Timeline: Received: October 14, 2026; Revised: November 13, 2026; Accepted: November 27, 2026; Published: November 30, 2026

African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 964–971

DOI: 10.46882/AJIDR/149038

Article Type: Research Article

Title: Antimicrobial resistance determinants and virulence plasmid carriage in Klebsiella aerogenes nosocomial bloodstream infections

Names of Authors: Yusuf Al-Jamil¹*, Klara Lindqvist², Diego Morales-Reyes³

Abstract: Klebsiella aerogenes is an opportunistic Enterobacterales pathogen capable of developing rapid derepressed AmpC beta-lactamase resistance during third-generation cephalosporin therapy. We evaluated inducible AmpC hyperproduction, carbapenemase genes, and clinical mortality predictors among bacteremic inpatients. Non-duplicate bloodstream isolates from 104 hospitalized adults underwent broth microdilution, whole-genome sequencing, and clinical chart review. Resistance to ceftriaxone and cefepime was observed in 48.1 percent and 17.3 percent of isolates respectively, whereas meropenem and amikacin retained over 94.0 percent activity. Avoiding third-generation cephalosporins for invasive infections prevents treatment failure.

Keywords: Klebsiella aerogenes, AmpC beta-lactamase, Nosocomial bacteremia, Antimicrobial resistance, Enterobacterales

Citation: Al-Jamil Y, Lindqvist K, Morales-Reyes D (2026). Antimicrobial resistance determinants and virulence plasmid carriage in Klebsiella aerogenes nosocomial bloodstream infections. African Journal of Infectious Diseases Research, 13(11): 964–971. DOI: 10.46882/AJIDR/149038

Manuscript Timeline: Received: October 13, 2026; Revised: November 12, 2026; Accepted: November 27, 2026; Published: November 30, 2026

African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 956–963

DOI: 10.46882/AJIDR/149037

Article Type: Research Article

Title: Prevalence, genotype diversity, and antiviral susceptibility of human metapneumovirus in hospitalized older adults with acute respiratory distress

Names of Authors: Sophie Laurent-Dubois¹*, Chukwuemeka Eze², Haruto Takahashi³

Abstract: Human metapneumovirus causes substantial seasonal morbidity and hypoxic respiratory failure in older adults and individuals with chronic cardiopulmonary comorbidities. We characterized fusion gene subgroups, viral co-infection rates, and intensive care admission predictors among hospitalized seniors. Nasopharyngeal swabs from 330 adults aged 65 years and older were tested via multiplex reverse transcription polymerase chain reaction and phylogenetic sequencing. Subgroups A2b and B1 accounted for 71.5 percent of confirmed cases, with secondary bacterial pneumonia occurring in 24.8 percent of patients. Routine multiplex viral testing reduces unnecessary antibiotic exposure.

Keywords: Human metapneumovirus, Geriatric respiratory infection, Viral pneumonia, Phylogenetic analysis, Respiratory viruses

Citation: Laurent-Dubois S, Eze C, Takahashi H (2026). Prevalence, genotype diversity, and antiviral susceptibility of human metapneumovirus in hospitalized older adults with acute respiratory distress. African Journal of Infectious Diseases Research, 13(11): 956–963. DOI: 10.46882/AJIDR/149037

Manuscript Timeline: Received: October 12, 2026; Revised: November 11, 2026; Accepted: November 26, 2026; Published: November 30, 2026

African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 948–955

DOI: 10.46882/AJIDR/149036

Article Type: Research Article

Title: Molecular surveillance and fexinidazole treatment outcomes in second-stage Trypanosoma brucei gambiense human African trypanosomiasis

Names of Authors: Jean-Paul Kabongo¹*, Astrid Lindberg², Rajesh Nair³

Abstract: Gambiense human African trypanosomiasis is a fatal vector-borne protozoan disease targeting the central nervous system if left untreated during the hemolymphatic stage. We assessed diagnostic sensitivity of loop-mediated isothermal amplification, cerebrospinal fluid white cell counts, and oral fexinidazole cure rates. Blood and cerebrospinal fluid specimens from 94 seropositive patients were examined at baseline and 12 months post-treatment. Oral fexinidazole achieved a 92.6 percent treatment success rate in late-stage disease without requiring routine lumbar puncture in non-severe presentations. All-oral therapy accelerates sleeping sickness elimination.

Keywords: Trypanosoma brucei gambiense, African trypanosomiasis, Fexinidazole, Neglected tropical diseases, Protozoan infections

Citation: Kabongo J, Lindberg A, Nair R (2026). Molecular surveillance and fexinidazole treatment outcomes in second-stage Trypanosoma brucei gambiense human African trypanosomiasis. African Journal of Infectious Diseases Research, 13(11): 948–955. DOI: 10.46882/AJIDR/149036

Manuscript Timeline: Received: October 11, 2026; Revised: November 10, 2026; Accepted: November 26, 2026; Published: November 30, 2026

African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 940–947

DOI: 10.46882/AJIDR/149035

Article Type: Research Article

Title: Serotype distribution and beta-lactamase resistance profiles of Haemophilus influenzae in pediatric community-acquired pneumonia

Names of Authors: Katarina Horvat¹*, Kwabena Osei², Min-Jae Kim³

Abstract: Haemophilus influenzae remains a major respiratory pathogen in young children, with non-typeable strains increasingly implicated in invasive and mucosal infections following Hib vaccination. We determined capsular genotypes, blaTEM-1 carriage, and penicillin-binding protein 3 mutations among pediatric respiratory isolates. Induced sputum and blood cultures from 265 hospitalized children were evaluated via slide agglutination, multiplex polymerase chain reaction, and broth microdilution. Non-typeable Haemophilus influenzae accounted for 83.4 percent of isolates, with beta-lactamase-negative ampicillin-resistant strains representing 16.2 percent. Amoxicillin-clavulanate and third-generation cephalosporins remain reliable empirical therapies.

Keywords: Haemophilus influenzae, Pediatric pneumonia, Beta-lactamase resistance, Non-typeable strains, Respiratory pathogens

Citation: Horvat K, Osei K, Kim M (2026). Serotype distribution and beta-lactamase resistance profiles of Haemophilus influenzae in pediatric community-acquired pneumonia. African Journal of Infectious Diseases Research, 13(11): 940–947. DOI: 10.46882/AJIDR/149035

Manuscript Timeline: Received: October 10, 2026; Revised: November 09, 2026; Accepted: November 25, 2026; Published: November 30, 2026

African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 932–939

DOI: 10.46882/AJIDR/149034

Article Type: Research Article

Title: Genomic characterization and clinical manifestations of Toxoplasma gondii ocular retinochoroiditis in immunocompetent adults

Names of Authors: Adesola Adeyemi¹*, Henrik Lindstrom², Camila Delgado³

Abstract: Ocular toxoplasmosis is a leading infectious cause of posterior uveitis and irreversible visual impairment in both congenital and postnatally acquired infections. We investigated parasite multilocus genotypes, aqueous humor viral-parasitic co-infections, and visual acuity outcomes among patients with active retinochoroiditis. Aqueous humor aspirates and serum samples from 82 patients were analyzed via B1 gene quantitative polymerase chain reaction and restriction fragment length polymorphism typing. Atypical recombinant genotypes predominated in 54.9 percent of intraocular samples and correlated with severe vitritis. Prompt trimethoprim-sulfamethoxazole and corticosteroid therapy preserves retinal function.

Keywords: Toxoplasma gondii, Ocular toxoplasmosis, Retinochoroiditis, Posterior uveitis, Molecular genotyping

Citation: Adeyemi A, Lindstrom H, Delgado C (2026). Genomic characterization and clinical manifestations of Toxoplasma gondii ocular retinochoroiditis in immunocompetent adults. African Journal of Infectious Diseases Research, 13(11): 932–939. DOI: 10.46882/AJIDR/149034

Manuscript Timeline: Received: October 09, 2026; Revised: November 08, 2026; Accepted: November 25, 2026; Published: November 30, 2026